← Open Payments lookup

VILAS PATIL: Open Payments

NPI 1417044983 · OSWEGO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,169 in 59 payments from 9 companies in 2025. Trend: 2023 $184 · 2024 $789 · 2025 $1,169

Food & beverage: $1,169
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.7$217
Alkermes, Inc.9$166
Teva Pharmaceuticals USA, Inc.11$146
ABBVIE INC.11$137
Otsuka America Pharmaceutical, Inc.8$136
E.R. Squibb & Sons, L.L.C.5$130
Janssen Pharmaceuticals, Inc3$99
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$91
Luye Pharma (USA) Ltd.2$47

Products named: INGREZZA, VRAYLAR, COBENFY, ABILIFY ASIMTUFII, UZEDY, ARISTADA, INVEGA SUSTENNA, CAPLYTA.

Industry payments across NY — which companies pay providers there.